A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

ClinicalTrials.gov ID: NCT07199465

Public ClinicalTrials.gov record NCT07199465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 2:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Open-label, Single-arm Study to Evaluate the Pharmacokinetics and Safety of Letermovir in Pediatric Kidney Transplant (KT) Recipients Less Than 18 Years of Age and Weighing Less Than 40 Kilograms

Study identification

NCT ID: NCT07199465
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Enrollment: 40 participants

Conditions and interventions

Conditions

Cytomegalovirus Prophylaxis

Interventions

Letermovir Drug

Drug

Eligibility (public fields only)

Age range: Up to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 29, 2026
Primary completion: Apr 13, 2028
Completion: May 18, 2028
Last update posted: May 11, 2026

2026 – 2028

United States locations

U.S. sites: 14
U.S. states: 10
U.S. cities: 14

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham - School of Medicine - Pediatrics ( Site 0019)	Birmingham	Alabama	35233	Recruiting
UCLA Clinical & Translational Research Center (CTRC) ( Site 0006)	Los Angeles	California	90095	Recruiting
Lucile Packard Children's Hospital ( Site 0001)	Palo Alto	California	94304	Recruiting
University of California Davis Health ( Site 0023)	Sacramento	California	95817	Recruiting
UCSF Medical Center at Mission Bay ( Site 0017)	San Francisco	California	94158	Recruiting
Children's Hospital Colorado ( Site 0013)	Aurora	Colorado	80045	Recruiting
University of Miami School of Medicine ( Site 0021)	Miami	Florida	33136	Recruiting
Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 0004)	Chicago	Illinois	60611	Recruiting
University of Michigan ( Site 0014)	Ann Arbor	Michigan	48109	Recruiting
M Health Fairview University of Minnesota Masonic Children's Hospital, West Bank ( Site 0007)	Minneapolis	Minnesota	55454	Recruiting
Mayo Clinic - Rochester ( Site 0015)	Rochester	Minnesota	55905	Recruiting
Morgan Stanley Children's Hospital ( Site 0018)	New York	New York	10032	Recruiting
Duke University Medical Center ( Site 0008)	Durham	North Carolina	27710	Recruiting
Cincinnati Children's Hospital Medical Center ( Site 0002)	Cincinnati	Ohio	45229	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07199465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 11, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07199465 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →